Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B

Fig. 3

Evolution of eGFR by PEG-IFN-α-2a therapy in treatment-naïve patients or ETV-experienced CHB patients over 48 weeks. a Changes of eGFR as calculated by CKD-EPI formula. b Changes of eGFR as calculated by MDRD formula. “#” symbol indicated P < 0.05, “##” symbol indicated P < 0.01, and “###” symbol indicated P < 0.001

Back to article page